| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 34661-75-1 | 烏拉地爾; 6-{3-[4-(2-甲氧基苯基)-1-哌嗪基]-丙基氨基}-1,3-二甲基脲嘧啶 | Urapidil; 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil |  | C20H29N5O3 | 詳情 | 供應商 |
| 89315-19-5 | Glycine, N-L-leucyl-,2-[[5-(dimethylamino)-1-naphthalenyl]sulfonyl]hydrazide (9CI); dansylhydrazide-leucyl-glycine |  | C20H29N5O4S | 詳情 | 供應商 | |
| 59184-78-0 | Urea,N-butyl-N'-[1-(6,7-dimethoxy-4-quinazolinyl)-4-piperidinyl]-; BDPU; Buquineran; UK 14275 |  | C20H29N5O3 | 詳情 | 供應商 | |
| 76953-65-6 | 2-Propanone,2-[6-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxypropoxy]-3-pyridazinyl]hydrazone; 3(2H)-Pyridazinone,6-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-2-hydroxypropoxy]-,(1-methylethylidene)hydrazone (9CI); Dramedilol |  | C20H29N5O4 | 詳情 | 供應商 | |
| 102432-83-7 | 3,27,28-Trioxa-10,13,16,19,22-pentaazatricyclo[22.2.1.15,8]octacosa-5,7,24,26-tetraene-9,23-dione |  | C20H29N5O5 | 詳情 | 供應商 |